TMLR联合VEGF基因治疗缺血心肌后心肌灌注和代谢的变化

The change of myocardial perfusion and metabolism after TMLR and intramyocardial administration of VEGF165 cDNA

  • 摘要: 目的: 观察TMLR联合VEGFDNA165治疗后心肌灌注和代谢的变化。方法: 动物(犬)随机分成假手术组、心肌梗死组、TMLR组、TMLR+VEGF165cDAN组(n=1 2)。采用正电子断层扫描(PET)检查不同时期实验区心室壁节段心肌灌注和代谢变化。结果: TMLR联合VEGF165cDNA组治疗后6周和1 2周,前壁、前侧壁、前间壁灌注量和FDG明显高于单纯TMLR组(P<0.05);TMLR组6周和1 2周缺血心肌对FDG摄入和心肌灌注较心肌梗塞组无统计学差异。结论: TMLR+VEGF165cDNA治疗后6周和1 2周时心肌灌注量和心肌摄入FDG较单纯TMLR显著增加,提示成活心肌的数量显著增加和或成活心肌功能显著恢复。

     

    Abstract: Objective: To determine the change of myocardial perfusion and metabolism after TMLR combined intramyocardial administration of VEGF165C DNA. Methods: The 48 dogs were rand omly divided into 4 groups(n=12),fake group,myocardial infarction、T MLR and T MLR+VEGF165cDNA group.Regional myocardial perfusion and metabolism were detected with postron emission tomography. Results: the amount of perfusion and intake of FDG of anterial、anterial lateral and anterial septum of left vetricular wall in T MLR +VEGF165cDNA group are larger than that in T MLR group after six weeks and twelve weeks. Conclusion: a quantity of viable myocardium are striking increase and /or function of viable myocardium are striking recovery after T MLR and intramyocardial administration of VEGF165cDNA.

     

/

返回文章
返回